Doug Hampton

ANTECH DIAGNOSTICS PRESENTS LARGEST MOLECULAR STUDY ON GI PARASITES IN PETS AT ACVIM, SHARING NEW INSIGHTS ON PREVALENCE IN NORTH AMERICA

by

Results data drawn from a subset of samples tested in KeyScreen® GI Parasite PCR’s first 10 months shows widespread problem with parasites in dogs and cats FOUNTAIN VALLEY, Calif., June 16, 2023 /PRNewswire/ — Antech Diagnostics presented its largest molecular parasite study1 to date at the American College of Veterinary Internal Medicine’s (ACVIM) Forum 2023. The first … Read more

La NABR conteste l’inscription du macaque à longue queue à la liste de l’UICN

by

WASHINGTON, 16 juin 2023 /PRNewswire/ — En collaboration avec des scientifiques reconnus et indépendants, l’Association nationale pour la recherche biomédicale (NABR, National Association for Biomedical Research) a déposé aujourd’hui une requête auprès de l’Union internationale pour la conservation de la nature (UICN), contestant la récente désignation du macaque à longue queue (Cynomolgus macaque) comme espèce … Read more

Novavax entregará la vacuna XBB COVID monovalente según la recomendación VRBPAC de la FDA para el otoño

by

­­- Novavax está preparado para entregar la vacuna XBB COVID monovalente a base de proteínas de acuerdo con la recomendación VRBPAC de la FDA para el otoño Novavax ha desarrollado una candidata a vacuna contra la COVID XBB.1.5 monovalente a base de proteínas y se está fabricando a escala comercial con la intención de estar … Read more

Actinium Pharma to Present at the Maxim Healthcare Virtual Conference

by

NEW YORK, June 16, 2023 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that the Company will participate in a fireside chat at the Maxim Healthcare Virtual Conference on Wednesday, June 21, 2023 at 12:30 PM EST. This conference will be … Read more

11 Stories You Need to See

by

A roundup of the week’s most newsworthy health industry press releases from PR Newswire, including a mental health startup focused on culturally-responsive care. NEW YORK, June 16, 2023 /PRNewswire/ — With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the … Read more

Investments By Various Multinational Enzyme Manufacturers Drive Growth

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Specialty Enzymes Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Proteases, Polymerases & Nucleases, Carbohydrase’s, Lipases, and Others), By Source, By Application, By Region” report has been added to  ResearchAndMarkets.com’s offering. Global Specialty Enzymes Market is anticipated to witness a robust CAGR in the … Read more

FORESEE PHARMACEUTICALS ANNOUNCES POSTER PRESENTATION AND PARTICIPATION AT THE WASOG 2023 INTERNATIONAL CONFERENCE ON SARCOIDOSIS AND INTERSTITIAL LUNG DISEASES (ILDs)

by

Poster on FP-020, a follow-on, best-in-class, oral MMP-12 inhibitor in a genetic model of sarcoidosis includes efficacy, biomarkers and complete translational cellular profiling supporting novel anti-inflammatory and anti-fibrotic mechanism TAIPEI, June 16, 2023 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the company will be participating and presenting a poster at the WASOG 2023 … Read more

Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca

by

SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets … Read more

Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca

by

SHANGHAI, June 16, 2023 /PRNewswire/ — Cholesgen (Shanghai) Co.Ltd. (‘Cholesgen’) today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with AstraZeneca. This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint research effort will leverage complementary strengths and focus on selected targets … Read more

At L’Oustal high school, home help in the spotlight through an exhibition

by

the essential The L’Oustal high school is hosting an exhibition entitled “What talent!” until June 21. This exhibition is an educational, social and cultural innovation project that contributes to the promotion and attractiveness of the home help professions. Capucine de Decker is the organizer of the Pôle Culture et Santé Nouvelle Aquitaine, a structure at … Read more